Q3 2024 |
80 |
$18.9B |
+$3.9B |
-$2.29B |
+$1.61B |
QXO, UNH, CPAY, IBKR, RXO
|
13F-HR |
11/14/2024, 12:09 PM |
Q2 2024 |
76 |
$16.1B |
+$1.33B |
-$1.66B |
-$331M |
UNH, CPAY, IBKR, SHEL, GXO
|
13F-HR |
8/14/2024, 10:27 AM |
Q1 2024 |
71 |
$16.7B |
+$3.14B |
-$3.91B |
-$772M |
CPAY, UNH, IBKR, GXO, GPN
|
13F-HR |
5/15/2024, 01:48 PM |
Q4 2023 |
73 |
$15.9B |
+$1.64B |
-$1.03B |
+$605M |
FLT, GXO, GPN, INTC, CEG
|
13F-HR |
2/14/2024, 12:44 PM |
Q3 2023 |
76 |
$13.9B |
+$1.11B |
-$1.31B |
-$199M |
FLT, GXO, GPN, IBKR, CEG
|
13F-HR |
11/14/2023, 01:27 PM |
Q2 2023 |
73 |
$14B |
+$1.6B |
-$1.21B |
+$398M |
FLT, GXO, GPN, IBKR, TSM
|
13F-HR |
8/14/2023, 10:33 AM |
Q1 2023 |
72 |
$12.7B |
+$1.56B |
-$2.05B |
-$491M |
FLT, GXO, GPN, TSM, IBKR
|
13F-HR |
5/15/2023, 08:22 AM |
Q4 2022 |
78 |
$12.6B |
+$1.51B |
-$2.26B |
-$753M |
FLT, GXO, GPN, GOOG, AES
|
13F-HR |
2/14/2023, 10:51 AM |
Q3 2022 |
72 |
$12.2B |
+$1.51B |
-$777M |
+$728M |
FLT, GPN, SHEL, GXO, PGR
|
13F-HR |
11/14/2022, 07:51 AM |
Q2 2022 |
73 |
$12.4B |
+$2.49B |
-$1.88B |
+$608M |
FLT, GPN, BTI, PGR, HWM
|
13F-HR |
8/15/2022, 01:52 PM |
Q1 2022 |
74 |
$13.7B |
+$2.39B |
-$2.32B |
+$72.9M |
UNH, FLT, GPN, XPO, ELV
|
13F-HR |
5/16/2022, 11:12 AM |
Q4 2021 |
63 |
$13.5B |
+$1.44B |
-$3.21B |
-$1.76B |
UNH, GXO, XPO, NTES, ELV
|
13F-HR |
2/14/2022, 12:43 PM |
Q3 2021 |
62 |
$14.6B |
+$2.72B |
-$2.2B |
+$524M |
NTES, XPO, GXO, CMCSA, UNH
|
13F-HR |
11/15/2021, 11:14 AM |
Q2 2021 |
65 |
$15.8B |
+$1.71B |
-$1.02B |
+$689M |
NTES, XPO, CMCSA, ELV, BTI
|
13F-HR |
8/16/2021, 11:28 AM |
Q1 2021 |
63 |
$14B |
+$1B |
-$1.59B |
-$588M |
NTES, XPO, ELV, CMCSA, HWM
|
13F-HR |
5/17/2021, 03:30 PM |
Q4 2020 |
61 |
$13.8B |
+$2.22B |
-$2.06B |
+$160M |
NTES, XPO, ELV, ABBV, CMCSA
|
13F-HR |
2/16/2021, 12:00 PM |
Q3 2020 |
61 |
$12.7B |
+$841M |
-$2.15B |
-$1.31B |
NTES, XPO, ELV, ABBV, CMCSA
|
13F-HR |
11/16/2020, 10:53 AM |
Q2 2020 |
61 |
$13.3B |
+$1.44B |
-$1.42B |
+$24.5M |
NTES, XPO, ABBV, ELV, BTI
|
13F-HR |
8/14/2020, 02:48 PM |
Q1 2020 |
63 |
$10.4B |
+$1.87B |
-$2.82B |
-$956M |
NTES, ABBV, XPO, ELV, ATHM
|
13F-HR |
5/15/2020, 10:15 AM |
Q4 2019 |
63 |
$14.3B |
+$1.05B |
-$1.9B |
-$847M |
NTES, XPO, ABBV, ATHM, ELV
|
13F-HR |
2/14/2020, 12:13 PM |
Q3 2019 |
60 |
$13.5B |
+$760M |
-$1.26B |
-$501M |
NTES, XPO, ABBV, ATHM, CELG
|
13F-HR |
11/14/2019, 09:12 AM |
Q2 2019 |
57 |
$13.9B |
+$1.07B |
-$1.9B |
-$832M |
NTES, ABBV, XPO, ATHM, CELG
|
13F-HR |
8/14/2019, 10:56 AM |
Q1 2019 |
57 |
$14.7B |
+$1.3B |
-$1.55B |
-$247M |
NTES, ABBV, CELG, XPO, ATHM
|
13F-HR |
5/15/2019, 04:34 PM |
Q4 2018 |
54 |
$13.9B |
+$1.56B |
-$2.04B |
-$481M |
NTES, ABBV, XPO, CELG, ATHM
|
13F-HR |
2/14/2019, 10:14 AM |
Q3 2018 |
52 |
$17.4B |
+$1.61B |
-$2.47B |
-$857M |
NTES, XPO, ABBV, CELG, VALE
|
13F-HR |
11/14/2018, 04:25 PM |
Q2 2018 |
60 |
$18B |
+$3.33B |
-$2.61B |
+$726M |
NTES, XPO, ABBV, META, CELG
|
13F-HR |
8/14/2018, 04:28 PM |
Q1 2018 |
59 |
$17.5B |
+$3.93B |
-$3B |
+$925M |
XPO, NTES, ABBV, SYMC, L100PS
|
13F-HR |
5/15/2018, 10:47 AM |
Q4 2017 |
58 |
$17B |
+$2.22B |
-$2.75B |
-$535M |
XPO, NTES, ABBV, CHTR, L100PS
|
13F-HR |
2/14/2018, 12:37 PM |
Q3 2017 |
65 |
$16.2B |
+$1.93B |
-$2.61B |
-$679M |
XPO, ABBV, CHTR, NTES, JD
|
13F-HR |
11/14/2017, 02:34 PM |
Q2 2017 |
62 |
$15.9B |
+$2.17B |
-$1.83B |
+$338M |
XPO, CHTR, ABBV, JD, ELV
|
13F-HR |
8/14/2017, 02:28 PM |
Q1 2017 |
63 |
$14.6B |
+$3.13B |
-$3.58B |
-$457M |
CHTR, XPO, JD, ELV, APA
|
13F-HR |
5/15/2017, 01:50 PM |
Q4 2016 |
65 |
$13.9B |
+$1.75B |
-$2.38B |
-$634M |
CHTR, QCOM, XPO, APA, NTES
|
Restatement |
3/10/2017, 05:33 PM |
Q3 2016 |
1 |
$8.41M |
$0 |
$0 |
|
SRAQ
|
New Holdings |
12/12/2016, 06:07 PM |
Q3 2016 |
75 |
$14.3B |
+$1.3B |
-$1.9B |
-$609M |
NTES, QCOM, CHTR, APA, XPO
|
13F-HR |
11/14/2016, 09:41 AM |
Q2 2016 |
77 |
$13.1B |
+$2.71B |
-$2.48B |
+$232M |
NTES, QCOM, CHTR, APA, JD
|
13F-HR |
8/15/2016, 08:25 AM |
Q1 2016 |
82 |
$12.3B |
$0 |
$0 |
|
NTES, QCOM, MSI, APA, JD
|
Restatement |
5/27/2016, 11:50 AM |